Traditional Chinese Medicine for Coronary Heart Disease: Clinical Evidence and Possible Mechanisms

Ke-Jian Zhang,Qun Zheng,Peng-Chong Zhu,Qiang Tong,Zhuang Zhuang,Jia-Zhen Zhu,Xiao-Yi Bao,Yue-Yue Huang,Guo-Qing Zheng,Yan Wang
DOI: https://doi.org/10.3389/fphar.2019.00844
IF: 5.6
2019-08-02
Frontiers in Pharmacology
Abstract:Coronary heart disease (CHD) remains a major cause of mortality with a huge economic burden on healthcare worldwide. Here, we conducted a systematic review to investigate the efficacy and safety of Chinese herbal medicine (CHM) for CHD based on high-quality randomized controlled trials (RCTs) and summarized its possible mechanisms according to animal-based researches. 27 eligible studies were identified in eight database searches from inception to June 2018. The methodological quality was assessed using seven-item checklist recommended by Cochrane Collaboration. All the data were analyzed using Rev-Man 5.3 software. As a result, the score of study quality ranged from 4 to 7 points. Meta-analyses showed CHM can significantly reduce the incidence of myocardial infarction and percutaneous coronary intervention, and cardiovascular mortality (P < 0.05), and increase systolic function of heart, the ST-segment depression, and clinical efficacy (P < 0.05). Adverse events were reported in 11 studies, and CHMs were well tolerated in patients with CHD. In addition, CHM exerted cardioprotection for CHD, possibly altering multiple signal pathways through anti-inflammatory, anti-oxidation, anti-apoptosis, improving the circulation, and regulating energy metabolism. In conclusion, the evidence available from present study revealed that CHMs are beneficial for CHD and are generally safe.
pharmacology & pharmacy
What problem does this paper attempt to address?